By On Thursday, October 5th, 2017 Categories : Health


Mycophenolate mofetil (emblem call CellCept) is a drug that has been shown to inhibit tumor growth in rodents, and that can prove useful in treating tumors in humans.








In August 2000, the Food and Drug Administration (FDA) authorized using mycophenolate mofetil in sufferers undergoing liver transplants, and the drug is used usually to ease the attractiveness of a transplanted organ with the aid of a recipient. The drug makes attractiveness of the transplanted organ much more likely as it prevents the recipient from mounting an immune reaction to the organ, or treating it like a foreign invader. The drug additionally seems to have the capacity to inhibit tumor increase, and may prove powerful in treating certain varieties of cancer. In laboratory studies, mycophenolate mofetil has inhibited tumor boom in cancers of the pancreas, colon, lung, and blood. The cost of the drug for anticancer therapy continues to be being evaluated.